AB Science Masivet Drug Shelf Life Extended to Four Years
The European Medicines Agency (EMA) has approved an extension of the shelf life for AB Science's Masivet to four years. This decision applies to all manufactured batches of the product.
AB Science announced that the European Medicines Agency (EMA) has approved an extension of the shelf life for its veterinary drug Masivet to four years. The approval covers all manufactured batches of the product.
Masivet contains masitinib and is used in veterinary medicine. Extending the shelf life is expected to reduce waste, improve logistics, and enhance the availability of the drug for animal clinics.
AB Science is a pharmaceutical company focused on developing new drugs. The company aims to improve human and animal health by identifying, developing, and commercializing innovative molecules.
The extended shelf life could also contribute to improved cost-effectiveness and resource management within the healthcare supply chain.